Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Bange
Bernhard Bange, Leverkusen DE
| Patent application number | Description | Published |
|---|---|---|
| 20090020050 | Roller grate with hydraulic drive and a method for operating the roller grate - A roller grate consists of rollers disposed one behind the other by means of which the material to be burned is moved, and of a drive for the rollers that constitutes a hydraulic motor for driving one or several rollers. A method for operating the roller grate consists of operating the hydraulic motor in angular steps. The roller grate has the advantage that roller grates having low-weight drive units can be operated with high reliability and with little wear of the drive units. | 01-22-2009 |
Gert Bange, Heidelberg DE
| Patent application number | Description | Published |
|---|---|---|
| 20090017510 | Enzymic method for the enantioselective reduction of keto compounds - The invention relates to an enzymatic method for the enantioselective reduction of organic keto compounds to the corresponding chiral hydroxy compounds, an alcohol dehydrogenase from | 01-15-2009 |
James Crawford Bange, Corning, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110129784 | LOW THERMAL EXPANSION DOPED FUSED SILICA CRUCIBLES - The present disclosure relates to a silica-based crucible material that includes, before sintering or firing, selected amounts of a thermal expansion stabilizer component (B | 06-02-2011 |
Joe Bange, Eagan, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20090058635 | Medical data transport over wireless life critical network - A portable patient communicator (PPC) includes a portable housing that supports a processor coupled to memory for storing medical firmware and wireless radio firmware, first and second radios, a processor, and a power source. Communications between a patient implantable medical device (PIMD) and the first radio of the PPC are effected in accordance with program instructions of the medical firmware, and communications between the second radio of the PPC and the wireless network are effected in accordance with program instructions of the wireless radio firmware. Data from the PIMD is received via the first radio to which a priority level is assigned, such as in a tiered manner. A data transport mechanism is selected among disparate data transport mechanisms based at least in part on the priority level. PIMD data is transmitted to the wireless network using the selected transport mechanism via the second radio. | 03-05-2009 |
Johannes Bange, Neuried DE
| Patent application number | Description | Published |
|---|---|---|
| 20090123462 | FGFR AGONISTS - The present invention relates to the use of Fibroblast-Growth Factor Receptor (FGFR) agonists for the diagnosis, prevention and/or treatment of pathological conditions including, but not limited to hyperproliferative disorders, bone diseases and vascular diseases. Particularly, the use of FGFR-4 agonists, e.g. anti-FGFR-4 antibodies is described. Further, the invention relates to a pharmaceutical composition comprising the agonist as described above and a screening procedure. | 05-14-2009 |
Johannes Bange, Munchen DE
| Patent application number | Description | Published |
|---|---|---|
| 20100184686 | USE OF INHIBITORS FOR THE TREATMENT OF RTK-HYPERFUNCTION-INDUCED DISORDERS, PARTICULARLY CANCER - The present invention concerns the use of inhibitors for the treatment and/or prophylaxis of diseases which are the consequence of increased receptor tyrosine kinase activity, particularly cancer. The use is particularly directed towards inhibition or lowering of the overexpression and/or altered activity of receptor tyrosine kinases (RTKs). In particular, this altered activity of receptor tyrosine kinase can be triggered by a mutation of FGFR-4, wherein this mutation is in particular a point mutation in the transmembrane domain of FGFR-4 and leads to an exchange of a hydrophobic amino acid for a hydrophilic amino acid. The invention further concerns the use of an inhibitor directed against FGFR-4, for the treatment and/or prophylaxis of cancer. Furthermore, the invention concerns a mutated FGFR-4, which leads to over-expression and/or altered activity in cells. Finally, the invention concerns a DNA and RNA sequence of a mutated FGFR-4 molecule. Finally, in addition the invention concerns a pharmaceutical composition, containing the inhibitor as described above and further a diagnostic and screening procedure. | 07-22-2010 |
Johannes Bange, Planegg DE
| Patent application number | Description | Published |
|---|---|---|
| 20100169992 | FGFR4 ANTIBODIES - The present invention relates to FGFR4 antibodies including fragments or derivatives thereof and the polynucleotides encoding the antibodies. Expression vectors and host cells comprising the polynucleotides are provided. Further, the invention refers to pharmaceutical compositions comprising the FGFR4 antibodies and methods for the treatment, prevention or diagnosis of disorders associated with FGFR4 expression. | 07-01-2010 |
Olof Bange, Hoganas SE
| Patent application number | Description | Published |
|---|---|---|
| 20100291506 | DEVICE FOR DEBRIDEMENT OF IMPLANTS, AND A METHOD FOR DEBRIDEMENT OF IMPLANTS USING THE DEVICE | 11-18-2010 |
| 20100330531 | BRIDGE SUPPORT, A SCREW AND A METHOD - A bridge support ( | 12-30-2010 |
Paul Bange, Regenstauf DE
| Patent application number | Description | Published |
|---|---|---|
| 20100204871 | MOTOR VEHICLE MONITORING APPARATUS AND ASSOCIATED METHOD FOR CONTROLLING THE ELECTRIC CURRENT OF AN ACTUATOR - A motor vehicle monitoring apparatus has a controller as a component of a control loop for controlling the electric current of an actuator. The vehicle power supply system voltage of a motor vehicle voltage source is applied to the actuator. A correction unit is provided in the forward path of the control loop between the controller and a subordinate actuator element of the control loop and applies the actuation signal output by the controller with a correction factor which is proportional to the reciprocal value of the instantaneous vehicle power supply system voltage. | 08-12-2010 |